[Life-threatening hypokalemic paralysis in carbenoxolone therapy].
D002229:Carbenoxolone / Q000009:adverse effects* / Q000627:therapeutic use; D003300:Copper / Q000097:blood; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced* / Q000201:enzymology; D007501:Iron / Q000097:blood; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000187:drug effects; D009212:Myoglobinuria; D010243:Paralysis / Q000139:chemically induced* / Q000201:enzymology; D010437:Peptic Ulcer / Q000188:drug therapy; D012018:Reflex / Q000187:drug effects; D000637:Transaminases / Q000032:analysis; D014315:Triterpenes / Q000009:adverse effects*; D014882:Water-Electrolyte Balance
D014315:Triterpenes; D003300:Copper; D007501:Iron; D000637:Transaminases; D002229:Carbenoxolone
Vital bedrohliche hypokaliämische Lähmung unter Carbenoxolontherapie,-Fallbericht